<DOC>
	<DOCNO>NCT00590967</DOCNO>
	<brief_summary>Recent study show chance survival among woman advance cervical cancer increase receive concurrent chemotherapy radiation pelvis . However , patient advance disease show loco-regional failure well high incidence distant metastasis . Positron emission tomography ( PET ) scan high sensitivity specificity detection pelvic para-aortic lymph node metastasis . While detection para-aortic metastasis PET significantly impact prognosis , PET known show positive lymph node metastasis pelvis detect micrometastatic disease para-aortic lymph node ( despite fact histologically know ) . In addition , patient positive para-aortic lymph node PET , great amount ( 45 Gy ) radiation must use improve probability control cancer . However , dose great limited dose volume limit small bowel . But , Intensity Modulated Radiation Therapy ( IMRT ) new way calculate deliver radiation therapy . Compared external beam radiation , IMRT improve ability deliver large dos radiation specific target minimize exposure surround normal tissue . With IMRT , however , effective dose/volume increase safely low toxicity surround tissue , thus make prophylactic dose para-aortic lymph node detect PET safer effective .</brief_summary>
	<brief_title>A Phase II Study Extended Field IMRT External Beam Irradiation Intracavitary Brachytherapy</brief_title>
	<detailed_description>Prior entrance study , patient undergo history physical evaluation Karnofsky Performance Status . They biopsy tumor undergo fluorodeoxyglucose ( FDG ) PET scan must include evaluation para-aortic lymph node . Blood work do ( complete blood count ( CBC ) , differential , platelet , blood urea nitrogen ( BUN ) , serum creatinine , bilirubin , aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) alkaline phosphatase . Also , pre-treatment , patient receive chest x-ray intravenous push ( IVP ) ( unless compute tomography ( CT ) contrast perform ) . Additionally , patient may undergo CT , magnetic resonance ( MRI ) and/or lymphangiogram . Patients register treatment arm , depend outcome PET scan . Patients positive pelvic lymph node positive para-aortic lymph node PET assign Treatment Arm 1 . Patients positive pelvic lymph node positive para-aortic lymph node PET assign treatment arm 2 . Treatment Group 1 . Either conventional CT simulation may perform . Patients treat IMRT extend field external beam radiation therapy ( cover pelvis para-aortic lymph node ) intracavitary radiation ( 6 high dose radiation ( HDR ) treatment ) concurrently cisplatin ( 40 mg/m^2/week ) Treatment Group 2 . A CT simulation must perform . Patients treat extended field external beam radiation therapy pelvis IMRT cover para-aortic lymph node 60 Gy , 50.4 Gy para-aortic lymph node bed conjunction external beam pelvic radiation therapy appropriate disease stage intracavitary radiation ( 6 HDR treatment ) concurrently cisplatin ( 40 mg/m^2/week ) .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients must carcinoma uterine cervix . Patients squamous cell , adenocarcinoma , adenosquamous carcinoma eligible . International Federation Gynecology Obstetrics ( FIGO ) Stage I IVA Patients must evidence metastatic disease outside pelvis ( except paraaortic node ) , PET . Patients must Karnofsky Performance Status &gt; = 60 medical contraindication administration chemotherapy . Age &gt; = 18 . Adequate bone marrow function : white blood cell ( WBC ) &gt; = 4000/mm3 , platelet &gt; = 100,000 mm3 . Adequate renal function : BUN &lt; = 25 mg/dl , creatinine &lt; = 1.2 mg/dl ( urinary diversion permit improve renal function ) . Patients must bilirubin &lt; = 1.5 mg/dl . Signed studyspecific inform consent . No positive lymph node FDG PET Positive supraclavicular lymph node FDG PET Scan evidence distant disease . FIGO Stage IVB+ Cervical Cancer No prior ( within 5 year ) simultaneous malignancy ( cutaneous basal cell carcinoma ) . Karnofsky Performance Status &lt; 60 . Patients significant medical illness preventing use full dose chemotherapy exclude . Patients follow histology exclude : small cell , carcinoid , glassy cell , clear cell adenoid cystic . Life expectancy &lt; 6 month . Patients poorly control diabetes mellitus ( fast blood glucose level &gt; 200 mg/dL ) eligible . No prior surgery treatment disease exploratory laparotomy biopsy . No previous systemic chemotherapy . No pelvic radiation therapy permit transvaginal irradiation control bleed . Pregnant woman ineligible childbearing potential practice contraception . Patients abnormal liver function test</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>para-aortic lymph node</keyword>
</DOC>